ASX - By Stock
|
ARX |
Re:
chart
|
|
nottawombat
|
13 |
4.5K |
0 |
12:25 |
12:25 |
ASX - By Stock
|
13
|
4.5K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
chart
|
|
nottawombat
|
13 |
4.5K |
0 |
11:48 |
11:48 |
ASX - By Stock
|
13
|
4.5K
|
0
|
|
ASX - By Stock
|
ARX |
Re:
chart
|
|
nottawombat
|
13 |
4.5K |
0 |
11:41 |
11:41 |
ASX - By Stock
|
13
|
4.5K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
nottawombat
|
97 |
21K |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
97
|
21K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
nottawombat
|
97 |
21K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
97
|
21K
|
4
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
nottawombat
|
954 |
435K |
3 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
954
|
435K
|
3
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
nottawombat
|
954 |
435K |
4 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
954
|
435K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
nottawombat
|
97 |
21K |
15 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
97
|
21K
|
15
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
nottawombat
|
120 |
26K |
9 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
120
|
26K
|
9
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
1 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
138
|
49K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
138
|
49K
|
2
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
0 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
138
|
49K
|
0
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
nottawombat
|
250 |
62K |
2 |
06/06/24 |
06/06/24 |
ASX - By Stock
|
250
|
62K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
775 |
189K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
775
|
189K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
nottawombat
|
250 |
62K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
250
|
62K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
2 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
2
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
nottawombat
|
250 |
62K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
250
|
62K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
nottawombat
|
250 |
62K |
5 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
250
|
62K
|
5
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 200th patient treated with the OncoSil device
|
|
nottawombat
|
35 |
6.5K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
35
|
6.5K
|
0
|
|
ASX - By Stock
|
BML |
Re:
Share Price after raise.
|
|
nottawombat
|
53 |
13K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
53
|
13K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 200th patient treated with the OncoSil device
|
|
nottawombat
|
35 |
6.5K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
35
|
6.5K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
775 |
189K |
3 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
775
|
189K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
1 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
0 |
05/06/24 |
05/06/24 |
ASX - By Stock
|
138
|
49K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: 200th patient treated with the OncoSil device
|
|
nottawombat
|
35 |
6.5K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
35
|
6.5K
|
2
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
138
|
49K
|
2
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
138
|
49K
|
5
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
138
|
49K
|
4
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
2 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
138
|
49K
|
2
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
nottawombat
|
250 |
62K |
5 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
250
|
62K
|
5
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
nottawombat
|
120 |
26K |
3 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
120
|
26K
|
3
|
|
ASX - By Stock
|
EBR |
Re:
Charting
|
|
nottawombat
|
250 |
62K |
4 |
04/06/24 |
04/06/24 |
ASX - By Stock
|
250
|
62K
|
4
|
|
ASX - By Stock
|
DRO |
Re:
AU$1.25 on no news?
|
|
nottawombat
|
138 |
49K |
1 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
138
|
49K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron appoints Dr Cathryn Clary as Chief Medical Advisor
|
|
nottawombat
|
97 |
21K |
9 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
97
|
21K
|
9
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
nottawombat
|
148 |
46K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
148
|
46K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
nottawombat
|
54 |
20K |
2 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
54
|
20K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
nottawombat
|
102 |
24K |
4 |
02/06/24 |
02/06/24 |
ASX - By Stock
|
102
|
24K
|
4
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
nottawombat
|
102 |
24K |
4 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
102
|
24K
|
4
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
nottawombat
|
1.1K |
415K |
3 |
01/06/24 |
01/06/24 |
ASX - By Stock
|
1.1K
|
415K
|
3
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
nottawombat
|
102 |
24K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
24K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
nottawombat
|
102 |
24K |
11 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
24K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
nottawombat
|
102 |
24K |
11 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
24K
|
11
|
|
ASX - By Stock
|
PER |
Re:
Ann: Phase IIb study of ATL1102 in DMD completes recruitment
|
|
nottawombat
|
102 |
24K |
3 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
102
|
24K
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Investor Presentation
|
|
nottawombat
|
120 |
26K |
5 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
120
|
26K
|
5
|
|
ASX - By Stock
|
PME |
Re:
Ann: Update - Notification of buy-back - PME
|
|
nottawombat
|
39 |
13K |
1 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
39
|
13K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: ProstACT SELECT Study of TLX591 rADC Therapy - Positive rPFS
|
|
nottawombat
|
148 |
46K |
22 |
31/05/24 |
31/05/24 |
ASX - By Stock
|
148
|
46K
|
22
|
|